hero-654791312-sized

Ensights

Science that is transforming lives and enabling the future

Entegris and Farrar Scientific Announce New Collaboration

Entegris and Farrar Scientific Announce New Collaboration

Entegris is proud to announce a new relationship with Farrar Scientific, by Trane Technologies – a global climate innovator. Farrar offers best-in-class operating systems for ultra-cold temperature storage and controlled rate freeze/thaw chambers for pharmaceutical, biotech, and biorepository applications. Entegris offers the best-in-class Aramus™ bag for robust cold storage and transport. Collaborating with Farrar enables Entegris to offer a combined solution that accelerates the freeze/thaw process. Powered by Trane Technologies, Farrar’s solutions fill an unmet need for large pharmaceutical and biopharmaceutical customers requiring flexible, modular, and efficient ultra-low temperature freeze/thaw processing, as well as -80°C (-112°F) bulk storage reach-ins and -70°C (-94°F) pallet chambers. Farrar’s offerings and monitoring services, which include predictive analytics, provide an alternative to large-scale freezer farms or capital-intensive cold rooms used in the manufacturing of drugs, vaccines, and other biological products. Forced air convection cooling in Farrar’s controlled rate chamber greatly reduces +40˚ to -80˚C (+104° to -112°F) freeze/thaw times from days or weeks to hours, optimizing manufacturing efficiency and improving characteristics such as uniformity and repeatability versus competing technologies."This collaboration is a win-win for the industry,” said Holly Paeper, president, Trane Technologies Life Science Solutions. “Farrar and Entegris solutions jointly represent a step forward in reliability, simplicity, and affordability for end-to-end bioprocessing. We’re excited to discover how we can jointly advance precision temperature technology that helps protect quality and optimizes manufacturing.” Entegris will showcase Farrar’s controlled rate chamber in our new Life Sciences Technology Center in Billerica, MA, which offers life sciences customers the opportunity to leverage our expertise in cold-chain challenges to reduce costs, increase speed to market, and optimize processes. This premier facility brings Entegris’ tools and technologies together in one place, where customers can test equipment for freeze/thaw processes to determine which products best fit their needs. As part of our solutions for manufacturing challenges, we now offer Aramus shaped 2D single-use bags with custom shapes, sizes, and assembly configurations for customers’ space and function requirements. They are resistant to extreme cold temperatures and withstand gamma sterilization, which makes them a preferred solution for freezing, transporting, storing, and thawing drug substances, like COVID-19 vaccines, cell therapies, and gene therapies. “Our new technology center enables our customers to really understand the whole freezing process and optimize it before setting up a new lab of their own,” said John Lynch, vice president, Entegris. “Together with Farrar we are able to provide novel and high-value options for bulk drug freezing.”

  • September 19, 2022

Entegris and HOF begin Partnership to bring Added Value to Biopharm Bulk Drug Substance, Cold Storage, and Transport

Entegris is proud to announce a new relationship with HOF Sonderanlagenbau GmbH, an international provider of freeze/thaw equipment and special solutions for the pharmaceutical and biotechnology sectors. Entegris offers the best-in-class Aramus™ bag for robust cold storage and transport. Collaborating with HOF enables Entegris to offer a combined solution for our customers that accelerate the freeze/thaw process and help showcase our new Life Sciences Technology Center, built to offer customers the opportunity to leverage our cold-chain supply expertise to optimize processes, reduce costs, and increase speed to market.

  • September 14, 2022

Congratulations to Our 2020 Inventors and IP Award Winners!

To keep pace with the global demand and the rapid advancements in technology, the microelectronics industry depends heavily on innovating new solutions and processes to enable accelerated device production and performance. At Entegris, we are very proud to honor nearly 200 employees from our global technical community for their inventions and contributions to our intellectual property in 2020.

  • April 8, 2021

2019 End of Year Highlights

Entegris Highlights 2019 2019 was a year of exciting change and significant accomplishments for Entegris including strategic acquisitions, supplier awards, footprint expansions and technology center openings, sustained Five+ Sigma quality levels, hundreds of issued technology patents, and so much more!

  • February 6, 2020

A Mandate for the Future: Operational Excellence in the Supply Chain

What should you look for in a materials supplier to ensure quality, reliability and safety? Listen as Entegris' Sandrine Felix, senior manager, solutions marketing, interviews Neil Richards, senior VP, global operations & supply chain, to get his perspective on what it takes to be a world-class specialty materials supplier.

  • October 21, 2019

Entegris Expands Portfolio with DSC and MPD Chemicals Acquisitions

Technologies like AI, IoT, and virtual reality are changing the way people live across the globe. To achieve the performance for these technologies, manufacturers have adopted new, more complex chip designs. These changes have increased the demands on the materials used in all steps of semiconductor processing. 

  • August 21, 2019

Let's Reflect: Q2 2019

Q2 was full of celebrations with the Anniversary of Moore’s Law and Global Internet of Things (IoT) Day. Check out more of Q2’s highlights and join us as we continue to fuel the Fourth Industrial Revolution and travel down the road to “smart everything.”

  • August 7, 2019

Saving You Now, but Costing You Later

Buyer beware Today’s fast-paced semiconductor manufacturing industry is dynamic, and competition is stronger than ever. To stay competitive, suppliers and manufacturers seek to reduce costs wherever possible. Be careful those cost saving initiatives do not lead to buying products that compromise safety and performance in semiconductor manufacturing.

  • August 1, 2019

Q1 2019 Highlights

Take a look back at our successes in the first quarter of 2019. A record quarter for liquid filtration and 50 patents granted, worldwide, are among a few of those accomplishments. We also continued our investment in emerging talent with our co-op program that we are expanding globally. Take a look at some of those co-ops and the other highlights from Q1.

  • May 2, 2019

A Look Back at 2018

We are proud of our accomplishments in 2018 and we are looking ahead to what we can achieve in 2019.

  • April 3, 2019
    Content not found

    Related Posts